Systematic review of the treatment of rheumatoid arthritis patients of reproductive age: informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication
- 8 October 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 36 (2) , 181-189
Abstract
Objectives: To inform the 2024 updates of the Japanese College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis of the safety of maternal and paternal exposure to disease-modifying antirheumatic drugs (DMARDs). Methods: We searched the databases of PubMed, the Cochrane Library, and the Japana Centra Revuo Medicina for articles published between 2019 and 2022 and combined them with our previous systematic review. Two independent reviewers screened articles, evaluated core outcomes, and performed meta-analyses for each clinical question. Results: The relative effects (odds ratio (OR) [95% confidence interval (95% CI)]) of tumour necrosis factor inhibitor (TNFi) exposure on the infants of pregnant women with rheumatoid arthritis were as follows: major birth defects, 1.51 [0.89, 2.58]; and serious neonatal infections, 1.20 [0.84, 1.71]. The relative effects (OR [95% CI]) of paternal antirheumatic drugs exposure on major birth defect in infants were 1.30 [0.28, 6.14] for TNFi and 0.94 [0.38, 2.33] for methotrexate. Conclusions: This systematic review provided the latest evidence on effects of maternal and paternal exposure to DMARDs on their infants for the 2024 update of the clinical practice guidelines.Keywords
Funding Information
- Ministry of Health, Labour and Welfare of Japan (22FE1002)
This publication has 19 references indexed in Scilit:
- Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flareArchives of Gynecology and Obstetrics, 2022
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal DiseasesArthritis & Rheumatology, 2020
- Factors Associated With Preterm Delivery Among Women With Rheumatoid Arthritis and Women With Juvenile Idiopathic ArthritisArthritis Care & Research, 2019
- Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive ReportAmerican Journal of Gastroenterology, 2018
- Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)American Journal of Gastroenterology, 2018
- Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor InhibitorsArthritis & Rheumatology, 2018
- Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre studyJoint Bone Spine, 2017
- Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before ConceptionAmerican Journal of Gastroenterology, 2016
- Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational studyReproductive Toxicology, 2014
- Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validityJournal of Clinical Epidemiology, 2013